{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:07:34Z","timestamp":1777100854837,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["GZY-KJS-2023-028"],"award-info":[{"award-number":["GZY-KJS-2023-028"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["SDFEYBS2408"],"award-info":[{"award-number":["SDFEYBS2408"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860477"],"award-info":[{"award-number":["81860477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403716"],"award-info":[{"award-number":["82403716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115651","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:34:26Z","timestamp":1759793666000},"page":"115651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Plumbagin remodels the tumor immune microenvironment to overcome cisplatin resistance in tongue squamous cell carcinoma via KLF2 activation and ZWINT\/NF-\u03baB inhibition"],"prefix":"10.1016","volume":"166","author":[{"given":"Zichen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingkun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiyang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115651_bb0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2025.115651_bb0010","series-title":"Tongue Cancer. StatPearls. Treasure Island (FL) Ineligible Companies. Disclosure: Antonio Riera March Declares no Relevant Financial Relationships with Ineligible Companies","author":"Gonzalez","year":"2025"},{"key":"10.1016\/j.intimp.2025.115651_bb0015","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2018\/e478s","article-title":"DNA repair pathways and cisplatin resistance: an intimate relationship","volume":"73","author":"Rocha","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.intimp.2025.115651_bb0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0968-0004(00)89095-7","article-title":"Cisplatin and DNA repair in cancer chemotherapy","volume":"20","author":"Zamble","year":"1995","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2025.115651_bb0025","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1002\/cam4.3440","article-title":"The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis","volume":"9","author":"Troiano","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2025.115651_bb0030","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8(+) T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115651_bb0035","first-page":"682","article-title":"Role of noncoding RNAs in the tumor immune microenvironment of hepatocellular carcinoma, journal of clinical translational","volume":"11","author":"Lv","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.115651_bb0040","article-title":"Exhausted CD8+T cells in the tumor immune microenvironment: new pathways to therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115651_bb0045","first-page":"146","article-title":"Reversing T-cell exhaustion in Cancer: lessons learned from PD-1\/PD-L1 immune checkpoint blockade, Cancer","volume":"10","author":"Budimir","year":"2022","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2025.115651_bb0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","article-title":"IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction","volume":"80","author":"Shiri","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.115651_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08830185.2024.2411998","article-title":"Transforming growth factor-beta in tumor microenvironment: understanding its impact on monocytes and macrophages for its targeting","volume":"44","author":"Hourani","year":"2025","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.115651_bb0060","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1158\/0008-5472.CAN-08-2494","article-title":"Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer","volume":"68","author":"Aziz","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115651_bb0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molonc.2012.12.001","article-title":"Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model","volume":"7","author":"Hafeez","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2025.115651_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jphs.2017.04.003","article-title":"Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2\/9 expression and inaction of PI3K\/Akt signaling pathway in vitro","volume":"134","author":"Chen","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2025.115651_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.intimp.2009.03.022","article-title":"Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes","volume":"9","author":"Checker","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115651_bb0080","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.18632\/oncotarget.3301","article-title":"Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data","volume":"6","author":"De Cecco","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2025.115651_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2407-6-224","article-title":"Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line","volume":"6","author":"Zhang","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2025.115651_bb0090","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.2147\/IJGM.S340057","article-title":"ZWINT is a promising therapeutic biomarker associated with the immune microenvironment of hepatocellular carcinoma","volume":"14","author":"Lin","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.intimp.2025.115651_bb0095","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.4049\/jimmunol.1600206","article-title":"Dendritic cell KLF2 expression regulates T cell activation and Proatherogenic immune responses","volume":"197","author":"Alberts-Grill","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115651_bb0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.immuni.2009.05.011","article-title":"KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors","volume":"31","author":"Weinreich","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115651_bb0105","doi-asserted-by":"crossref","first-page":"eadn2337","DOI":"10.1126\/science.adn2337","article-title":"KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection","volume":"387","author":"Fagerberg","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115651_bb0110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/cjop.CJOP-D-23-00001","article-title":"ZWINT promotes the proliferation, migration, and invasion of cervical cancer cells by regulating the p53\/p21 signaling pathway","volume":"66","author":"Ma","year":"2023","journal-title":"Chin. J. Phys."},{"key":"10.1016\/j.intimp.2025.115651_bb0115","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2025.115651_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/srep15431","article-title":"Zwint-1 is required for spindle assembly checkpoint function and kinetochore-microtubule attachment during oocyte meiosis","volume":"5","author":"Woo Seo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.115651_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081166","article-title":"Cisplatin-resistance in Oral squamous cell carcinoma: regulation by tumor cell-derived extracellular vesicles","volume":"11","author":"Khoo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2025.115651_bb0130","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.7150\/jca.46173","article-title":"Involvement of the NF-kappaB signaling pathway in proliferation and invasion inhibited by Zwint-1 deficiency in pancreatic Cancer cells","volume":"11","author":"Kim","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2025.115651_bb0135","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archotol.129.7.786","article-title":"Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H mice","volume":"129","author":"Mandpe","year":"2003","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.intimp.2025.115651_bb0140","doi-asserted-by":"crossref","first-page":"12225","DOI":"10.18632\/aging.205175","article-title":"Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin","volume":"15","author":"Xin","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.intimp.2025.115651_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3135470","article-title":"Establishment and identification of patient-derived xenograft model for Oral squamous cell carcinoma","volume":"2022","author":"He","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.intimp.2025.115651_bb0150","article-title":"Isolation of whole mononuclear cells from peripheral blood and cord blood","author":"Kanof","year":"2001","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.intimp.2025.115651_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/v15020365","article-title":"Human hematopoietic stem cell engrafted IL-15 transgenic NSG mice support robust NK cell responses and sustained HIV-1 infection","volume":"15","author":"Abeynaike","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2025.115651_bb0160","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/TP.0b013e3181a5cb07","article-title":"Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice","volume":"87","author":"Ito","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2025.115651_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mc.20031","article-title":"Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells","volume":"40","author":"Srinivas","year":"2004","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.intimp.2025.115651_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154655","article-title":"Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction","volume":"111","author":"Lin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.115651_bb0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/aps.2011.152","article-title":"Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-kappaB signaling pathway","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.115651_bb0180","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.3892\/ol.2016.5048","article-title":"Plumbagin inhibits cell proliferation and promotes apoptosis in multiple myeloma cells through inhibition of the PI3K\/Akt-mTOR pathway","volume":"12","author":"Wu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2025.115651_bb0185","first-page":"556","article-title":"Plumbagin inhibits tumor angiogenesis of gastric carcinoma in mice by modulating nuclear factor-kappa B pathway, Transl","volume":"9","author":"Yang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115651_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175716","article-title":"Plumbagin suppresses breast Cancer progression by downregulating HIF-1alpha expression via a PI3K\/Akt\/mTOR independent pathway under hypoxic condition","volume":"27","author":"Jampasri","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.115651_bb0195","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1172\/JCI41384","article-title":"Statin-induced Kruppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses","volume":"120","author":"Bu","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115651_bb0200","article-title":"Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway","volume":"2","author":"Au-Yeung","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.intimp.2025.115651_bb0205","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1535-7163.MCT-22-0323","article-title":"JAK: not just another kinase","volume":"21","author":"Agashe","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2025.115651_bb0210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2147\/OTT.S152138","article-title":"Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins","volume":"11","author":"Ying","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.intimp.2025.115651_bb0215","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1039\/b906257b","article-title":"Transport of live yeast and zebrafish embryo on a droplet digital microfluidic platform","volume":"9","author":"Son","year":"2009","journal-title":"Lab Chip"},{"key":"10.1016\/j.intimp.2025.115651_bb0220","first-page":"5511","article-title":"Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells","volume":"9","author":"Pan","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2025.115651_bb0225","first-page":"187","article-title":"The overexpression of ZWINT in integrated bioinformatics analysis forecasts poor prognosis in breast cancer, Transl","volume":"9","author":"Shao","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115651_bb0230","first-page":"1831","article-title":"ZWINT: a potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion","volume":"43","author":"Yang","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2025.115651_bb0235","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0347(200012)22:8<748::AID-HED2>3.0.CO;2-6","article-title":"Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB","volume":"22","author":"Kato","year":"2000","journal-title":"Head Neck"},{"key":"10.1016\/j.intimp.2025.115651_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101644","article-title":"CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells","volume":"31","author":"Qiao","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.intimp.2025.115651_bb0245","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1111\/jcmm.17998","article-title":"Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages","volume":"27","author":"Wu","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115651_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315384","article-title":"Programmed cell death-ligand 1 in head and neck squamous cell carcinoma: molecular insights, preclinical and clinical data, and therapies","volume":"23","author":"Meliante","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115651_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevOncog.2022044635","article-title":"Improving radiotherapy response in the treatment of head and neck Cancer","volume":"27","author":"Wicker","year":"2022","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.intimp.2025.115651_bb0260","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1158\/1078-0432.CCR-24-0473","article-title":"Eftilagimod alpha (soluble LAG3 protein) combined with Pembrolizumab as second-line therapy for patients with metastatic head and neck squamous cell carcinoma","volume":"30","author":"Forster","year":"2024","journal-title":"Clin. Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692501642X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692501642X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:00:56Z","timestamp":1763697656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692501642X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S156757692501642X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115651","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plumbagin remodels the tumor immune microenvironment to overcome cisplatin resistance in tongue squamous cell carcinoma via KLF2 activation and ZWINT\/NF-\u03baB inhibition","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115651"}}